Alberta Investment Management Corp Voyager Therapeutics, Inc. Transaction History

Alberta Investment Management Corp

  • $10.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 26, 2020
SELL
$10.01 - $13.75 $329,329 - $452,375
-32,900 Closed
0 $0
Q2 2020

Aug 11, 2020
BUY
$8.05 - $14.21 $264,845 - $467,509
32,900 New
32,900 $415,000
Q1 2020

May 08, 2020
SELL
$6.8 - $14.66 $375,360 - $809,232
-55,200 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$12.82 - $16.85 $707,664 - $930,120
55,200 New
55,200 $770,000

Others Institutions Holding VYGR

# of Institutions
130
Shares Held
34.7M
Call Options Held
39.7K
Put Options Held
34.6K
View Full List

About Voyager Therapeutics, Inc.

VYGR Quotes by TradingView
  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $219M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Alberta Investment Management Corp Portfolio

Follow Alberta Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email